http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109503495-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D235-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 |
| filingDate | 2018-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109503495-B |
| titleOfInvention | 2-imine benzimidazole compound and medical application thereof |
| abstract | The invention relates to a 2-imine benzimidazole compound and medical application thereof, belonging to the field of pharmaceutical chemistry and pharmacotherapeutics. The 2-imine benzimidazole compound shown in the formula I or the formula II or the pharmaceutically acceptable salt thereof provided by the invention can be applied to the preparation of medicaments related to leukemia, in particular to the preparation of mu opioid receptor antagonist medicaments. |
| priorityDate | 2018-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 57.